S&P Futures
2,496.75-4.25(-0.17%)Dow Futures
22,303.00-30.00(-0.13%)
| Previous Close | 107.17 |
| Open | 107.76 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's Range | 107.20 - 108.62 |
| 52 Week Range | 92.28 - 124.52 |
| Volume | 46,088 |
| Avg. Volume | 103,485 |
| Market Cap | 4.37B |
| Beta | 0.14 |
| PE Ratio (TTM) | 10.99 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Capital Cube•7 days ago
ETFs with exposure to Taro Pharmaceutical Industries Ltd. : September 14, 2017
Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Taro Pharmaceutical Industries Ltd. Here are 5 ETFs with the largest exposure to TARO-US. Comparing the performance and risk of Taro Pharmaceutical Industries Ltd. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower ... Read more (Read more...)
Capital Cube•9 days agoTaro Pharmaceutical Industries Ltd. :TARO-US: Earnings Analysis: Q1, 2018 By the Numbers : September 13, 2017
Categories: Yahoo FinanceGet free summary analysis Taro Pharmaceutical Industries Ltd. reports financial results for the quarter ended June 30, 2017. We analyze the earnings along side the following peers of Taro Pharmaceutical Industries Ltd. – Mylan N.V., Valeant Pharmaceuticals International Inc, Merck & Co., Inc., Pfizer Inc., Johnson & Johnson, Teva Pharmaceutical Industries Limited Sponsored ADR, GlaxoSmithKline ... Read more (Read more...)
Markit•10 days agoSee what the IHS Markit Score report has to say about Taro Pharmaceutical Industries Ltd.
Taro Pharmaceutical Industries Ltd NYSE:TARO
